Berta Ferrer Fábrega Institutions of which they are part Biomedical Research in Melanoma Vall Hebron Institut de Recerca Email Berta Ferrer Fábrega Email Institutions of which they are part Biomedical Research in Melanoma Vall Hebron Institut de Recerca
Projects Novel therapeutic topical approach for discoid lupus cutaneous (DLE) treatment IP: Cristina Solé Marce Collaborators: Berta Ferrer Fábrega, Gloria Aparicio Español Funding agency: Instituto de Salud Carlos III Funding: 99099 Reference: PI21/01869 Duration: 01/01/2022 - 31/12/2024 Oncogene-mediated intratumoral immune-cell populations at different organs as biomarkers of immunotherapy response IP: Juan Angel Recio Conde Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Sara Garcia Ortega Funding agency: Instituto de Salud Carlos III Funding: 341220 Reference: PI20/00384 Duration: 01/01/2021 - 31/12/2023 Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi- and immunetherapies IP: Juan Angel Recio Conde Collaborators: Berta Ferrer Fábrega Funding agency: Instituto de Salud Carlos III Funding: 96072.79 Reference: AC16/00019 Duration: 01/01/2017 - 31/12/2019 Vías de diseminación metastásica en distintos subtipos del melanoma maligno: Nuevos biomarcadores tumorales y dianas terapéuticas. IP: Juan Angel Recio Conde Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega Funding agency: Asociación Española Contra el Cáncer Funding: 212500 Reference: 2015/AECC-GCE/RECIO Duration: 01/07/2015 - 31/12/2020 Pagination Current page 1 Page 2 Next page › Last page »
